Responsiveness to the hepatitis B vaccine in Autistic child
Phase 3
- Conditions
- Autism.Childhood autism
- Registration Number
- IRCT20130904014562N2
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 105
Inclusion Criteria
Presence of autism in the child
Maximum age 15 years
Parental consent regarding the participation of their child in phlebotomy and vaccine injection
Exclusion Criteria
Parental dissatisfaction
HBs-Ab titer Existence or increase above 10 mIU/m
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The variable in the study is the HBs-Ab titre. By Booster injection HBs-Ab titer will be increased and marked by ELISA. Timepoint: Evaluation time is before vaccine administration and one month after vaccine injection. Method of measurement: ELISA method employed.
- Secondary Outcome Measures
Name Time Method